What is Autoimmunity BioSolutions?
Autoimmunity BioSolutions is a pioneering biotechnology firm dedicated to advancing precision immunotherapies for autoimmune conditions. The company's core mission involves creating genetically targeted treatments designed to restore normal immune function in specific patient populations. By integrating genetic insights with sophisticated therapeutic design, Autoimmunity BioSolutions aims to address the critical unmet needs of patients with refractory autoimmune diseases. Their biomarker-driven, personalized medicine strategy seeks to offer safer and more effective alternatives to conventional immunosuppressive therapies.
How much funding has Autoimmunity BioSolutions raised?
Autoimmunity BioSolutions has raised a total of $3.1M across 1 funding round:
Seed
$3.1M
Seed (2026): $3.1M with participation from Independent Capital Group and Eos BioInnovation, LLC
Key Investors in Autoimmunity BioSolutions
Independent Capital Group
Independent Capital Group AG is a multi-family office specializing in systematic investing and tailored investment solutions, aiming to maximize long-term risk-adjusted returns. They provide sophisticated investment management for high-net-worth individuals and families.
Eos BioInnovation, LLC
EOS Bioinnovation is a biotechnology company focused on biological research, sustainable bio-products, or agricultural biotechnology, potentially developing bio-based solutions or agricultural innovations within the bio-innovation sector.
What's next for Autoimmunity BioSolutions?
With this substantial enterprise-level funding, Autoimmunity BioSolutions is poised for significant expansion and further development of its groundbreaking therapeutic pipeline. The strategic investment from key backers will likely accelerate clinical trials, enhance research and development capabilities, and potentially broaden the company's market reach. This capital infusion positions Autoimmunity BioSolutions to solidify its standing in the competitive biotechnology landscape, driving innovation in autoimmune disease treatment and paving the way for future growth and potential commercialization.
See full Autoimmunity BioSolutions company page
